Edwards Lifesciences EMEA Selects ForeignExchange Translations

Edwards Lifesciences has officially sanctioned its relationship with ForeignExchange Translations Inc.
 
The 55-year-old heart valve and hemodynamic monitoring technology developer has selected ForeignExchange as a preferred supplier of translation services for its European, Middle Eastern and African (EMEA) operations. The two companies have worked together since 2008 to shorten translation times, reduce costs, and improve linguistic quality in the EMEA region through ForeignExchange’s Multilingual Compliance Process.
 
Edwards’ selection of ForeignExchange as a preferred translation partner in the EMEA region resulted from an extensive evaluation process. Under terms of the agreement, Newton, Mass.-based ForeignExchange will provide multi-lingual services to Edwards’ marketing, clinical research and corporate functions in the EMEA area.
 
“At ForeignExchange, we pride ourselves on our medical translation expertise,” said ForeignExchange President Andres Heuberger said. “Edwards’ selection of ForeignExchange is another example of our ability to offer fast, cost-effective, high-quality translations on a global scale to the world’s largest medical device and pharmaceutical companies.”
 
ForeignExchange Translations provides Internet globalization, software localization and medical translation solutions to life sciences firms, including such industry behemoths as Abbott Laboratories, Novartis AG, Johnson & Johnson and Covidien plc. The company’s solutions are based on its Multilingual Compliance Process, which combines expert linguists, best-of-breed technology and measurable translation quality in a scalable process that can be deployed in multiple languages simultaneously. Roughly 1,300 certified linguists provide translation services for 60 languages, including Arabic, Cambodian, Croatian, Estonian, Greek, Icelandic, Japanese, Latvian, Portugese, Slovak, Spanish and Vietnamese. ForeignExchange has offices in Broomfield, Colo.; Bloomington, Minn.; Halifax, Nova Scotia (Canada); Madrid, Spain; and Cambridge, United Kingdom.